Skip to main content
SpringerLink
Log in

Antineoplastics

Death on antineoplastics: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The patient received chemotherapy regimen consisting of rituximab, methotrexate, ifosfamide and cytarabine with or without thiotepa. Since it is unclear that the reported patient received thiotepa or not, we have not considered it as suspect.

Reference

  • Sumbul M, et al. A sequential administration of high dose methotrexate (HDMTX) - and high dose cytarabin (HDAraC)-based chemotherapy in elderly patients with primary central nervous system lymphoma (PCNSL). Oncology Research and Treatment 40 (Suppl. 3): 75, Sep 2017. Available from: URL: http://doi.org/10.1159/000479566 [abstract] - Germany

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1675, 35 (2017). https://doi.org/10.1007/s40278-017-37803-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-37803-1

Search

Navigation